Urinary Tract Infection Treatment Market is Expected to Grow USD 13,617.4 Million by 2034, with a 1.9% Compound Annual Growth Rate | FMI

The battle against Urinary Tract Infections (UTIs) is gaining momentum, reflected in the growth of the Urinary Tract Infection Treatment Market. This market is projected to reach a substantial USD 13,617.4 million by 2034, expanding from its current valuation of USD 11,244.0 million in 2024. While this indicates growth, the market is expected to expand …

Global Urinary Tract Infection Treatment Industry Poised for Steady Growth at 1.9% CAGR, Reaching US$13.62 Billion by 2034 | FMI

The Global Urinary Tract Infection Treatment Industry is on track for consistent growth, driven by rising prevalence and ongoing developments in treatment options. According to a recent market analysis, the market was valued at an estimated US$11.24 billion in 2024 and is projected to reach US$13.62 billion by 2034. This translates to a Compound Annual Growth Rate (CAGR) of 1.9%. The urinary …

Urinary Tract Infection Treatment Market will achieve a modest CAGR of 2% from 2022 to 2032, crossing the significant milestone of US$ 10.29 Billion.

The increasing prevalence of urinary tract infection (UTI) and the growth in the number of prescriptions of quinolone antibiotics are expected to fuel the growth of the Urinary Tract Infection Treatment Market size is anticipated to be over US$ 12.54 Billion in 2022. According to a new study published by Future Market Insights (FMI), the …